Aktienanalyse zu Avantor, Inc. (AVTR)AVTRAvantor, Inc.

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Avantor Inc is a good buy right now, trading at $14.58, which is above the average analyst target price of $14.39. The stock has shown a year-to-date change of +27.23%, indicating strong momentum. However, the main risk is the recent negative net income reported for Q3 2025, which was -711.8 million USD, highlighting potential volatility in earnings.